Navigation Links
Proteonomix Announces a Private Placement of $3.8 Million
Date:3/6/2012

HAWTHORNE, N.J., March 6, 2012 /PRNewswire/ -- Proteonomix, Inc. (OTC/BB: PROT) announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series E convertible preferred stock at an aggregate purchase price of approximately $3.8 million (which are convertible into a total of  895,291 shares of Proteonomix common stock) and Series A, Series B and Series C warrants to purchase an aggregate of  2,685,873 shares of Proteonomix common stock.  The preferred stock is convertible at any time into shares of Proteonomix common stock at a conversion price of $4.25 per share, subject to adjustment as provided in the certificate of designation.  The transaction is expected to close on or about March 8, 2012, subject to satisfaction of customary closing conditions. 

The warrants have an exercise price of $4.25 per share. The Series A warrants and Series B warrants are each immediately exercisable.  The Series C warrants become exercisable at any time and to the same extent that any portion of the Series B warrants are exercised.  The Series A and Series C warrants shall each have a term of five years from the issue date and the term of the Series B warrant is one year and two weeks from the issue date.  The warrants are also subject to full ratchet anti-dilution protection. Other than the exercise periods, all three series of warrants are identical. The Company will receive  up to an additional $11,414,960.25 if all warrants are exercised. 

The Company has agreed to file a registration statement with the Securities and Exchange Commission (SEC) within seven business days from the filing of its annual report for the year ended December 31, 2011, but in no event later than April 16, 2012, registering the resale of the shares of common stock issuable upon the exerci
'/>"/>

SOURCE Proteonomix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Updated: Life Technologies Announces Fourth Quarter and Fiscal Year 2011 Results
2. ARUP Laboratories Announces Creation of Business Innovations Division
3. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
4. Regeneron Announces March 2012 Investor Conference Presentations
5. MiMedx Group Announces 2011 Results
6. Pro-Dex, Inc. Announces the Sale Of Its Motor Business
7. PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
8. Innocoll Announces Successful End-of-Phase 2 Meeting with FDA for XaraColl® and Agreement of the Phase 3 Program
9. Neuralstem Announces Closing of $5.2-Million Registered Direct Offering
10. Regeneron Announces Presentation at the Leerink Swann 2012 Global Healthcare Conference
11. Silence Therapeutics Announces Board Changes and Appointment of New Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013   NineSigma , Inc., of ... its launch, NineSights.com is now the innovation ... the worldwide community of innovators. From technology ... experts, NineSights stands out for its large community of ... technical disciplines, all vetted by NineSigma. The community is ...
(Date:6/19/2013)... June 19, 2013 ... presents Innovative Drug Delivery Systems: ... Licensing Opportunities for Generic Pharmaceutical ... There are more than ... drugs approved all over the ...
(Date:6/19/2013)... Washington (PRWEB) June 18, 2013 A ... complex materials, costs and other trends will highlight technical ... Monterey, California this fall. In its 33rd year, the ... includes an exhibition of key suppliers, approximately 100 technical ... SPIE, the international society for optics and photonics ...
(Date:6/18/2013)... electric cars could be on roads across North America before ... by the United States Department of Energy, Los Alamos National ... is part of a team led by the Los Alamos ... expensive platinum catalysts in fuel cells. , "One of the ... is the cost of the units. The pure platinum needed ...
Breaking Biology Technology:NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3US and Canadian researchers drive towards cheaper fuel cells for electric cars 2
... , VANCOUVER, June 8 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ... that the U.S. Food and Drug Administration (FDA) has ... (IVC) Filter in the United States, for use in ... rights to market and distribute the Option IVC Filter, ...
... Diamyd Medical reported today,that the company has received approval from ... type 1 diabetes from 10 years,of age in the company,s ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080314/297194 ) , ... III studies, one in,Europe and one in the USA, comprising ...
... BEIJING, June 8 /PRNewswire-Asia-FirstCall/ ... "Yongye" or the "Company"), a,leading developer and distributor ... in the People,s Republic of China (PRC), today,announced ... Yongye,Nongfeng Biotechnology Co., Ltd. (,Yongye Nongfeng,), it has ...
Cached Biology Technology:Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter 2Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter 3Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter 4Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter 5Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter 6Diamyd(R) Phase III Study Approved for Younger Patients in the US 2Yongye Biotechnology International Receives License to Manufacture Products 2Yongye Biotechnology International Receives License to Manufacture Products 3
(Date:6/18/2013)... United Kingdom, the Energy Department,s National Renewable Energy ... recently published a paper describing a novel cellulose-degrading ... quadripunctata , commonly known as the gribble. ... a relatively unique ability to produce their own ... down the biomass they eat. New biomass-degrading enzymes ...
(Date:6/18/2013)... hacker lab. At Brandeis University, sophisticated computational models ... scientists understand the complex interplay between genomic data, ... outer "shell" critical for replication. ... are finding will help researchers alter virus assembly, ... Jason Perlmutter, first author of the scientific paper ...
(Date:6/18/2013)... Laboratory of Molecular Biology, has been honored as ... Award. Torrent is being recognized for his outstanding ... predict antimicrobial regions in proteins. Luis Rivas, Centro ... this algorithm to interrogate full genomes in order ... appealing results." , Torrent obtained his Ph.D. ...
Breaking Biology News(10 mins):Novel enzyme from tiny gribble could prove a boon for biofuels research 2Computer modeling technique goes viral at Brandeis 2The American Society for Microbiology honors Marc Torrent 2
... Mich.---North American forests appear to have a greater capacity ... had previously anticipated. As a result, they ... more than most scientists had thought, a U-M ecologist ... a 12-year study at an experimental forest in northeastern ...
... Va.R&D Magazine honored Office of Naval Research scientist Dr. ... award on Oct. 13 for the development of a ... special high-tech surface technology, HybridSil Fire/Blast, acts like a ... surface, making it blast-, ballistic- and fire-resistant. "You ...
... The data publishing workflow of eight journals published by ... Repository , facilitating data archiving for data files associated with articles ... new module of the online editorial management platform, Pensoft Journal ... PhytoKeys , MycoKeys , BioRisk , NeoBiota , ...
Cached Biology News:U-M ecologist: Future forests may soak up more carbon dioxide than previously believed 2U-M ecologist: Future forests may soak up more carbon dioxide than previously believed 3Spray-on protective coating wins 'R&D 100' Award 2Data publishing in Pensoft journals integrated with the Dryad Data Repository 2
... supplied as a 5x solution. Designed ... membrane-bound proteins without destroying antigenic binding ... radioisotopic signals from blots. Not recommended ... as a 5X solution sufficient to ...
... optimization kit is for fine-tuning the bombardment ... kit is recommended when you are first ... kit includes 0.25 g each of 0.6 ... gold microcarriers, 100 each of 9 rupture ...
... fully automated solution for cell culture ... for cell-line maintenance, expansion, harvesting and ... built upon standard, industry proven components: ... configuration capable of both rapid bulk ...
... is based on PI's experience in high-resolution ... a decade. PI Hexapods were originally used ... adjustments over wide ranges in small step ... freedom with 3 m minimum incremental motion ...
Biology Products: